Benzinga | Dec 10, 2020 10:24AM EST

Canaccord Genuity Maintains Buy on DexCom, Lowers Price Target to $435

Canaccord Genuity maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $475 to $435.